November 28, 2023 By Morgen Ahearn The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to findings of a new study from Gladstone Institutes. UCSF Anesthesia and Perioperative Care resident Alex Perez, MD, PhD, performed much of the computational work for this groundbreaking research. Read more on the Gladstone website.
Mar 17, 2026 Turning Clinical Uncertainty Into Discovery: The Work of Dr. Matthieu Legrand Announcement Research
